Inotek
Inspection success begins long before inspection day.
Most pharma facilities don’t struggle at inspection. They struggle at design stage — when regulatory consequences aren’t yet visible. Inotek structures that thinking before infrastructure crystallises.
Request a Design Advisory Callhow inotek is different
At Inotek, regulatory thinking leads infrastructure. We define the regulatory boundary before engineering begins. When that boundary is clear, design becomes traceable, validation becomes aligned, and inspection conversations become confident.
how we engage
Regulatory thinking leads. Everything else follows.
Start with the boundary.
Let design handle compliance.
Design the rationale.
Stay present through go-live.
Our methodology is not a checklist. It is a sequence.
Regulatory interpretation introduced late corrects problems. Introduced early, it prevents them. Every stage of our engagement is structured to embed compliance logic before infrastructure solidifies, not after.
How We Think
Regulatory Boundary First
Before engineering begins, we define the inspection landscape. Target agencies, market aspirations, jurisdiction-specific scrutiny patterns. This boundary governs all downstream decisions.
Compliance-Led Concept Design
Zoning decisions define contamination philosophy. Personnel and material flows reflect risk logic, not operational convenience. Every layout is a regulatory statement.
Engineering The Design Basis
The Basis of GMP Design is the intellectual spine of a facility. HVAC philosophy. Cleanroom classification. Utility redundancy strategy. Each traceable to its regulatory rationale.
Locking Design Intent
Under timeline and budget pressure, design drifts. A classification adjusted. A segregation barrier reconsidered. Individually minor. Collectively, they alter inspection posture. We govern against that.
Validation Embedded Early
Validation pathways are shaped by early decisions. We integrate qualification strategy, IQ/OQ/PQ logic, CCS alignment, Annex 15, at concept and engineering stage, not at commissioning.
Governance Through Go-Live
Design intent does not preserve itself. Projects evolve. Stakeholders change. Optimisation discussions emerge under pressure. Without oversight, early regulatory clarity erodes, gradually and often invisibly.
Our work
Proof of Philosophy
Our proof is not in scale. It is in decision transformation. Across engagements, concept zoning has been recalibrated to align with contamination risk. HVAC philosophies refined to reflect accurate segregation logic. Documentation architectures restructured to mirror operational reality. In each case, the intervention was not cosmetic. It was structural.
Where we are
Trusted by pharmaceutical manufacturers building for regulated markets across RussiaRussia, GCCGCC, AfricaAfrica, Southeast AsiaSoutheast Asia and the USAUSA
We engaged Inotek Technologies for the design and engineering of our pharmaceutical project, and from the early stages, their approach has been highly structured and insightful.
Aya AlHasan
Project Manager, Pharmotech, Iraq
Read our latest
The Compliance Desk
Regulatory landscapes evolve. Inspection patterns shift. Interpretation nuances change across jurisdictions. The Compliance Desk is where we reflect on those movements, examining recurring observation themes, analysing how regulatory modernisation impacts facility design, and publishing structured thinking for the life sciences community.
Quality Assurance vs. Quality Control in GMP: What Pharma Professionals Must Know
Digital GMP Compliance: Tools and Software for Real-Time Monitoring
Role of Quality Assurance in Pharmaceutical Industry
Why Early Pharmaceutical Compliance is Key to Pharma Project Success
The Real Cost of QA and QC Failures in Pharma: FDA 483 Observations & Lessons
Get in touch
Inspection readiness starts with one conversation.
Tell us about your facility — where it's going, what it needs to achieve. We'll tell you where the structural risks are.
Lets talk